Aesthetic before-and-after photo compliance guide — FTC, state medical boards and HIPAA
A working guide to before-and-after photography for medspa owners, plastic surgeons, dermatologists, aesthetic nurse injectors and the marketing teams that run their campaigns. Written against FTC 16 CFR Part 255 (as revised in 2023), the four highest-friction state medical board rules (Texas §165.5, California, Florida, New York), HIPAA 45 CFR 164.508 marketing authorisation and the current Meta and Google Ads platform policies.
- Every before-and-after photo used in advertising sits under three overlapping regimes: FTC endorsement and substantiation (16 CFR Part 255), the state medical board advertising rule in the state where the practice is licensed, and the HIPAA marketing authorisation requirement at 45 CFR 164.508.
- A HIPAA marketing authorisation for imagery is not the general treatment consent signed at intake. It must name the specific image, the specific purpose, the specific media surfaces (website, Meta, Google, TikTok, print), and it must be revocable in writing.
- The four states with the sharpest photo-compliance friction are Texas (22 TAC §165.5), California (B&P Code 651 plus MBC guidance), Florida (Rule 64B8-11.001) and New York (Education Law §6530). Each has its own take on retouching, typicality and disclosure.
- Social-media reuse is a fresh marketing act. Each new surface requires the underlying authorisation to cover it, and platform policies (Meta cosmetic-procedures rule, Google Ads healthcare policy) apply on top of federal and state rules.
- Common enforcement patterns include stock imagery represented as practice patients, retouched outcomes that overstate typicality, missing "individual results vary" context, and patient photos reused for years past the original authorisation window.
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Table of contents
- The three overlapping regimes
- FTC substantiation and typicality
- State medical board rules — TX, CA, FL, NY
- HIPAA marketing authorisation for imagery
- Types of consent — verbal, written, digital
- Release form anatomy
- Social-media reuse — Instagram, TikTok, Meta
- Google Ads and Meta Ads photo policy
- In-house operating model
- FAQ & related guides
The three overlapping regimes that govern before-and-after photos
Before-and-after photography sits at the intersection of federal consumer protection, state medical practice regulation and federal health privacy. Any one of the three can carry a photo into an investigation on its own. Aesthetic practice owners frequently discover this only after the letter arrives, because each regime is enforced by a different agency with a different investigative style.
The Federal Trade Commission polices the photo as advertising. Its authority runs from Section 5 of the FTC Act (15 USC §45) and its Endorsement Guides (16 CFR Part 255). The 2023 revision to the Endorsement Guides tightened three specific areas that matter here: what counts as a material connection to the endorser, when a depicted outcome must carry a typicality disclosure, and how "clear and conspicuous" is measured on social platforms and short-form video. The FTC does not pre-approve advertising; it acts on complaints, sweeps and self-initiated investigations, and its remedy set includes civil penalties, restitution and injunctive orders.
The state medical board polices the photo as advertising by a licensed healer. Every state has its own advertising rule; the four with the most operational friction in aesthetics are Texas (22 TAC §165.5), California (Business & Professions Code 651 read with the Medical Board of California guidance), Florida (Rule 64B8-11.001 and the 2021 cosmetic-surgery tightening) and New York (Education Law §6530). Board rules layer on requirements the FTC does not touch — specialty designation language, physician-direction disclosure for medspas, retouching prohibitions.
The Office for Civil Rights polices the photo as a use or disclosure of Protected Health Information. A photograph of an identifiable patient is PHI. Using or disclosing it for marketing without a HIPAA marketing authorisation under 45 CFR 164.508 is a Privacy Rule violation, and civil monetary penalties under HITECH tiers apply. The 2024-adjusted range runs from approximately USD 141 to USD 71,162 per violation, capped at approximately USD 2.13 million per identical provision per calendar year at the top tier.
FTC 16 CFR §255 — substantiation, typicality and material connection
The 2023 revision of the FTC Endorsement Guides was the most significant update to the endorsement framework since 2009. Three practical shifts matter for before-and-after imagery specifically.
Substantiation must exist at the moment of publication
A before-and-after photo is an implicit performance claim. Under 16 CFR §255.2, an advertiser must have a reasonable basis for the claim at the moment the advertisement is published. In aesthetics, the reasonable basis is the underlying clinical documentation for the depicted patient: the treatment plan, the dated pre-treatment photograph, the dated post-treatment photograph, the injector or surgeon of record, and any objective measurement (before-after ruler in the frame, standardised lighting, clinical scoring). "We think this outcome looks good" is not substantiation; a substantiation dossier is.
Typicality is measured by consumer expectation
Under §255.2(b), if a depicted result is not what consumers can generally expect from the advertised service, the advertisement must clearly and conspicuously disclose the generally expected performance. "Individual results vary" alone is not sufficient when the depicted result is dramatically atypical; the disclosure must give the consumer a fair sense of what is typical. In aesthetics, that means a phrasing such as "Results shown are individual; typical outcome ranges vary — book a consultation for a personalised expectation" rather than a bare disclaimer.
Material connection covers staff, influencers, family, discount
Under §255.5, any connection between the endorser and the seller that could materially affect the weight or credibility of the endorsement must be disclosed. In an aesthetic practice, material connections include: the endorser is a member of staff or the medical director, the endorser received free or discounted treatment, the endorser is a spouse or family member of an owner or provider, the endorser is a paid social-media influencer, or the endorser is a referring provider. Each of these is disclosable. A photograph of a staff-member patient with no disclosure of the employment relationship is a violation even if the outcome is truthful.
Clear-and-conspicuous on social and short-form video
The 2023 revision emphasised that "clear and conspicuous" must be measured on the actual surface. A disclosure that is legible in a magazine ad is not automatically clear-and-conspicuous in a fifteen-second Instagram Reel. Text disclosures on video must appear for a duration a viewer can actually read; audio disclosures must be paced to be understood; and disclosures cannot be hidden behind a "more" click, buried below the fold, or lost in a caption a viewer must expand to see. In practice, a burned-in on-screen disclosure that appears for at least three seconds is the operational minimum for short-form video.
State medical board rules — Texas, California, Florida, New York
State medical boards enforce advertising rules against the licensee, not the practice entity. That is why the aesthetic clinic owner who is a nurse or a business person may not be a direct target of state medical board action, but the medical director whose licence is on the door absolutely is. Four states illustrate the range of state-level friction on before-and-after photography.
Texas — 22 TAC §165.5
The Texas Medical Board treats a before-and-after photograph as advertising subject to the same false-and-misleading standard as any textual claim. Rule 165.5 prohibits statements or images that create an unjustified expectation, that use testimonials without substantiation, and that omit material information a reasonable consumer would need. Texas enforcement pattern in aesthetics has focused on retouched imagery that materially overstates outcome, stock imagery presented as practice patients, medspa advertising that does not disclose the delegating physician, and comparative language ("the best in Dallas") that lacks substantiation. Sanctions include remedial plans, formal complaints and administrative fines, with the Texas Attorney General available for civil penalty prosecution under the Texas Deceptive Trade Practices Act.
California — B&P Code 651 and MBC guidance
California's B&P Code Section 651 enumerates prohibited practices, and its testimonial-disclosure standard is stricter than the federal FTC baseline. For before-and-after photography, the operational effect is that atypical results require a clear-and-conspicuous "results not typical" disclosure on the same face of the advertisement, that stock imagery represented as patient outcomes is a specific enumerated violation, and that non-physician-owned medspa advertising must not obscure the physician's role. Section 651 also creates parallel civil exposure under B&P 17200, meaning a private plaintiff or the California Attorney General can bring an action separately from the Medical Board of California.
Florida — Rule 64B8-11.001
Florida's Rule 64B8-11.001 treats before-and-after photography as a specific category of advertising and requires the underlying substantiation to be produced on demand. The 2021 legislative and regulatory tightening in response to office-based surgical incidents brought additional scrutiny to cosmetic-surgery photography. The Florida Department of Health investigates on complaint and on referral from the Attorney General's consumer protection division, and administrative penalties commonly include fines, corrective advertising orders, and licence probation. The Florida Board of Medicine expects the substantiation file, the HIPAA authorisation and the ad file to be produced together.
New York — Education Law §6530
New York's Education Law §6530 addresses professional misconduct broadly, and misleading advertising falls under it. The New York State Department of Health and the Office of Professional Medical Conduct enforce, and imagery that misrepresents outcomes, that uses stock photography as patient work, or that promotes unapproved uses of prescription products can trigger a misconduct investigation. New York has been active on medspa oversight in recent years, and the intersection of imagery with corporate practice of medicine questions is a recurring theme.
HIPAA marketing authorisation for photographic imagery
Under the HIPAA Privacy Rule, a photograph of an identifiable patient is Protected Health Information. Using or disclosing PHI for marketing requires a written authorisation under 45 CFR 164.508. The general treatment consent signed at intake does not cover marketing — that is a separate document, and its specific content is prescribed by regulation.
What the authorisation must contain
A valid HIPAA marketing authorisation for a before-and-after image must contain: a specific and meaningful description of the information to be used or disclosed (the specific image or set of images, dated), the name of the person or class of persons authorised to use or disclose (the practice and its marketing agency by name), the name of the recipient (the practice and each downstream media surface by category), a description of each purpose (marketing on website, social media, print), an expiration date or event, a statement of the individual's right to revoke, a statement that PHI once disclosed may be re-disclosed and no longer protected, a statement that the practice may not condition treatment or payment on the authorisation, and the signature and date of the individual.
Financial-remuneration disclosure
If the practice receives direct or indirect financial remuneration from a third party in exchange for making the communication (for example, a device manufacturer paying for a testimonial campaign), the authorisation must state so on its face. This is the Omnibus Rule addition and it is treated seriously in enforcement.
Revocation
The authorisation must be revocable in writing. Practices must have an operational process for handling revocations: pulling the image from active use within a defined timeframe, notifying downstream vendors, and documenting the revocation in the patient's record. Revocation does not undo distribution that has already occurred, but it does bar future use.
Types of consent — verbal, written, digital
Aesthetic practices frequently confuse three different consent instruments. The confusion is expensive because none of them substitutes for the others.
- General treatment consent. Signed at intake, authorises the practice to treat the patient and to use PHI for treatment, payment and health-care operations under 45 CFR 164.506. It does not authorise marketing use of imagery.
- Verbal or informal photograph consent. A verbal "sure, you can post that" from a happy patient at the front desk is not a HIPAA-compliant marketing authorisation. It is at best a courtesy, and it will not survive an OCR audit or a state board complaint.
- Written HIPAA marketing authorisation. The 45 CFR 164.508 instrument described above. Wet-signature or compliant electronic signature. This is the primary instrument.
- Digital release with e-signature. Increasingly common through practice management systems such as JaneApp, Nextech, Aesthetic Record, Modernizing Medicine and similar. E-signature is valid under the E-SIGN Act (15 USC §7001) if the process meets the intent-to-sign and record-retention requirements, and it is HIPAA-compliant if the system provides an audit trail.
- Modelling release / photographic release. A creative-commons or influencer contract release. Useful for non-patient content but does not replace the HIPAA marketing authorisation for identifiable patient imagery.
The operational rule is simple: for any identifiable patient image used in marketing, the primary instrument is the written or e-signature HIPAA marketing authorisation. Everything else is supplementary.
Anatomy of a defensible before-and-after release form
Every aesthetic practice should have a documented release form for photographic marketing use. A defensible release has eleven sections. It is not a legal document you download once and forget — it is a living instrument reviewed annually against current FTC, state board and HIPAA guidance.
- Section 1 — patient identification and treatment context. Full name, date, provider of record, procedure(s) performed, and the specific dates the before and after images were captured.
- Section 2 — image inventory. Each image identified by file name or reference number, with a thumbnail preview attached. Blanket "any images" language is not compliant; the images must be specifically identified.
- Section 3 — purpose of use. Marketing generally is not enough. Specify: website (the practice's own domains), social media (Meta, Instagram, TikTok, X, YouTube by name), paid advertising (Google Ads, Meta Ads, TikTok Ads by name), print, out-of-home, editorial pitches, industry conferences.
- Section 4 — geographic and durational scope. Duration in years (typically two to five) with an explicit expiration date. Territory (typically United States, or United States and social-media global reach where applicable).
- Section 5 — retouching and editing scope. A statement that images may be adjusted for lighting normalisation, cropping and consistent framing, but not to alter the depicted clinical outcome.
- Section 6 — financial-remuneration disclosure. Whether the patient is receiving any consideration (free treatment, discount, cash payment) in exchange for the use, and whether any third party is paying the practice to run the campaign.
- Section 7 — revocation process. Right to revoke in writing, mechanism (email to a specific address, mail to a specific person), and the practice's operational timeframe for pulling the image once revoked.
- Section 8 — re-disclosure statement. Once the image is distributed on public platforms, third parties may re-share it and it is no longer protected by HIPAA in the hands of those third parties.
- Section 9 — no-conditioning statement. The practice may not condition treatment or payment on signing the authorisation. This is a specific HIPAA requirement.
- Section 10 — signature block. Patient signature and date; witness signature if used; e-signature audit trail reference if electronic.
- Section 11 — file retention pointer. Reference number linking the authorisation to the underlying substantiation file, the treatment record, and the ad-file archive.
What we found when we studied 555 US med spas on Google
Patients praise the care almost without exception. The one area where complaints outnumber praise is booking and communication, and that is where most med spas can win.
Full study · 555 US med spas across 20 metros · roughly ±4% nationally · review velocity and themes from a 115-spa subsample · verified against raw data.
Google Ads, Meta Ads and TikTok Ads — before-and-after photo policy
Platform policies sit on top of federal and state rules and can independently disqualify a compliant ad from running. The three ad platforms most used in US aesthetic marketing each treat before-and-after imagery slightly differently.
Google Ads
Google's Healthcare and Medicines policy restricts certain aesthetic categories, and its Personalised Advertising policy limits categorised targeting on health conditions. Before-and-after imagery is not per se prohibited but is scrutinised for shock-value framing, unrealistic outcome portrayal, and comparative superiority. Landing-page substantiation must match the ad; a "results in one visit" claim in the ad copy with substantiation only for multi-visit protocols will trigger disapproval.
Meta Ads
Meta's Cosmetic Procedures and Weight Loss policy is stricter than Google's on aesthetics. Meta has periodically prohibited certain before-and-after formats — split-screen dramatisations, zoomed-in body-part imagery presented in a way that "implies dissatisfaction" — and limits targeting on health-condition attributes. Personal Attributes rules bar assertion or implication that Meta knows a specific user's health condition; an ad that says "you have wrinkles, we can help" is a violation regardless of the underlying photo.
TikTok Ads
TikTok's Cosmetic Procedures policy varies by country and account status. Certain aesthetic categories are permitted only for verified providers, and before-and-after imagery must include age-gating in some jurisdictions. The platform's Community Guidelines prohibit graphic surgical footage; aesthetic before-and-after content must be non-graphic and non-clinical in tone.
What an aesthetic practice should build in-house
Photo intake protocol
Standardised lighting, framing, distance, and pose reference. Same camera, same room, same time-of-day where feasible. Metadata retained (timestamp, provider, device).
Consent-and-substantiation dossier
Every image tied to a signed HIPAA marketing authorisation, a substantiation file (treatment record extract), a typicality note, and a material-connection flag.
Named reviewer per campaign
A single named person walks each campaign through FTC 16 CFR §255, the relevant state medical board rule, HIPAA §164.508, and the platform policy for the ad account.
Retouching log
A retouching log tracks every adjustment made to a marketing image: lighting normalisation, cropping, contrast. Clinical-outcome alteration is a redline event that halts publication.
Revocation workflow
Documented process to pull an image from all active surfaces within 30 days of revocation, notify downstream vendors, and record the action in the patient record.
Six-year retention
Authorisations, substantiation files, ad files and revocation records retained for six years plus state overlay. Retrievable in under 48 hours if a board or OCR request lands.
Where photo compliance sits in the wider stack
Before-and-after photography clears a federal envelope — HIPAA, FTC, ADA, TCPA (if the campaign uses SMS or voice) and CAN-SPAM (if it uses email) — plus the state medical board layer and platform policy. Pricing for an outsourced compliance review of a photo library varies with volume: a targeted 25-asset audit typically prices from $2,500-$5,000, and a full aesthetic-practice photo-compliance retrofit from $10,000-$25,000 depending on the state, the platforms in use, and the retroactive consent work required. Ongoing retainers for aesthetic campaigns start at $2,000-$3,500 per month for review coverage on a rolling content calendar.
Before-and-after photo compliance — common questions
Do I need written patient consent for a before-and-after photo?
Yes. A signed HIPAA marketing authorisation under 45 CFR 164.508 must be on file before any identifiable patient image is used in advertising. It must name the specific image, the specific purpose, the specific media surfaces and an expiration date. General treatment consent is not sufficient.
Does the FTC require a disclaimer on before-and-after photos?
The FTC Endorsement Guides at 16 CFR Part 255 require that any depicted result the seller cannot substantiate as generally expected must carry a clear-and-conspicuous disclosure of what consumers can typically expect. An "individual results vary" line paired with substantiation is the minimum defensible pattern.
What does Texas Medical Board Rule 165.5 require?
22 TAC §165.5 treats a before-and-after photograph as advertising subject to the same false-and-misleading standard as textual claims. Retouching that materially alters outcome, stock imagery presented as practice patients, and photos without documented substantiation each fall under the rule.
Can I use before-and-after photos on Instagram or TikTok?
Each new platform surface requires the underlying HIPAA authorisation to cover that platform by name, plus platform-level policy (Meta cosmetic-procedures rule, TikTok cosmetic-procedures policy) applies on top of federal and state rules. A separate social-media release is standard.
What if a patient revokes consent after posting?
Under 45 CFR 164.508(b)(5), a HIPAA marketing authorisation must be revocable in writing. The practice must stop future use. Already-distributed copies outside the practice's control cannot be recalled, but no new distribution may occur, and downstream vendors should be notified.
Are influencer-taken before-and-after photos different?
Yes. Material connection must be disclosed under 16 CFR §255.5, the depicted outcome is subject to the same substantiation rule as a practice-produced image, and patient content of the influencer needs a HIPAA authorisation on file — not just the influencer contract.
How long must we retain consent files?
HIPAA record retention is six years from the date the authorisation was last in effect. State medical practice acts often layer on additional retention (seven years in Texas, permanent in some states for imaging). Retain the consent, substantiation and ad file together.
Can we run paid ads with before-and-after imagery?
Google Ads and Meta Ads permit before-and-after imagery in certain aesthetic categories subject to their healthcare and cosmetic-procedures policies. Substantiation, state board and HIPAA stack still applies, plus a documented review that the ad meets platform policy for the account's region.
What price range does an aesthetic photo-compliance retrofit typically run?
A targeted 25-asset audit typically prices from $2,500-$5,000. A full aesthetic-practice photo-compliance retrofit runs $10,000-$25,000 depending on state, platforms in use and retroactive consent work. Ongoing retainer coverage on a rolling content calendar starts at $2,000-$3,500 per month.
Is this legal advice?
No. This is marketing guidance reviewed against current FTC, state medical board and HIPAA rules. Consult a healthcare-marketing attorney licensed in your state and confirm any specific claim with the applicable board before publication.
Scope an aesthetic photo-compliance review
Book a 30-minute call with the Ichelon Consulting US leadership, email the US practice lead, or WhatsApp us in your time zone. Retainers are custom-scoped per engagement · monthly review coverage typically starts at $2,000-$3,500.
Continue the aesthetic compliance stack
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
Social-media reuse — Instagram, TikTok, Meta stories, YouTube shorts
Social-media reuse is where compliant practices most often trip. A single patient authorisation is treated as if it covers "everything the practice ever does with the image," when in fact the authorisation should specifically enumerate every intended surface. Three common failure modes recur.
Failure mode one — the platform not on the release
A release signed in 2021 that names Facebook and Instagram does not automatically cover TikTok. A release signed in 2023 that names TikTok does not cover Threads or a platform that did not exist at signing. The safer construction lists platforms by name and adds "and any successor or comparable platform launched during the term, subject to a good-faith practice determination of compatibility with these terms." Even with the safer language, an annual re-consent for high-value assets is prudent.
Failure mode two — the disclaimer that vanishes
A before-and-after image posted with a full disclaimer on Instagram may get re-cropped or re-purposed for a Reel where the disclaimer is no longer visible. The FTC treats each surface as its own advertisement, and the disclosure must be clear-and-conspicuous on each surface. In practice, this means the disclosure text should be burned into the image where feasible, or a caption-locked disclosure should be verified on every re-post.
Failure mode three — the influencer boost
An influencer posts a before-and-after and the practice boosts the post as an ad. The practice now bears advertiser responsibility for the substantiation, the typicality disclosure and the material-connection disclosure. Influencer contracts should require that the influencer post is boost-ready: it must include the material-connection disclosure, must have substantiation on file, and must not include a claim the practice cannot support.